Aurobindo Pharma
BSE: 524804 | NSE: AUROPHARMA | ISIN: INE406A01029 | Pharmaceuticals
Balance Sheet of Aurobindo Pharma |
------------------- in Rs. Cr. ------------------- |
|
Mar '04 |
Mar '05 |
Mar '06 |
Mar '07 |
Mar '08 |
 |
|
12 mths |
12 mths |
12 mths |
12 mths |
12 mths |
|
| Sources Of Funds |
|
|
|
|
| Total Share Capital |
25.38 |
25.39 |
26.63 |
26.67 |
26.88 |
| Equity Share Capital |
25.38 |
25.39 |
26.63 |
26.67 |
26.88 |
| Share Application Money |
35.00 |
35.00 |
0.04 |
0.02 |
0.00 |
| Preference Share Capital |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Reserves |
730.99 |
763.20 |
878.78 |
902.63 |
1,193.72 |
| Revaluation Reserves |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Networth |
791.37 |
823.59 |
905.45 |
929.32 |
1,220.60 |
| Secured Loans |
514.61 |
624.40 |
644.12 |
685.95 |
581.87 |
| Unsecured Loans |
103.78 |
204.72 |
561.10 |
1,290.39 |
1,173.78 |
| Total Debt |
618.39 |
829.12 |
1,205.22 |
1,976.34 |
1,755.65 |
| Total Liabilities |
1,409.76 |
1,652.71 |
2,110.67 |
2,905.66 |
2,976.25 |
|
Mar '04 |
Mar '05 |
Mar '06 |
Mar '07 |
Mar '08 |
|
|
12 mths |
12 mths |
12 mths |
12 mths |
12 mths |
|
| Application Of Funds |
|
|
|
|
| Gross Block |
584.41 |
746.47 |
913.64 |
944.29 |
1,132.01 |
| Less: Accum. Depreciation |
111.41 |
151.69 |
195.22 |
231.81 |
304.93 |
| Net Block |
473.00 |
594.78 |
718.42 |
712.48 |
827.08 |
| Capital Work in Progress |
111.60 |
176.50 |
145.45 |
183.14 |
124.69 |
| Investments |
148.89 |
151.27 |
174.16 |
202.73 |
287.95 |
| Inventories |
259.64 |
323.58 |
383.44 |
547.28 |
651.23 |
| Sundry Debtors |
456.85 |
441.38 |
569.00 |
624.41 |
798.97 |
| Cash and Bank Balance |
34.95 |
10.93 |
40.98 |
14.95 |
3.42 |
| Total Current Assets |
751.44 |
775.89 |
993.42 |
1,186.64 |
1,453.62 |
| Loans and Advances |
156.01 |
234.11 |
370.77 |
568.82 |
584.78 |
| Fixed Deposits |
2.46 |
2.87 |
101.09 |
485.12 |
235.90 |
| Total CA, Loans & Advances |
909.91 |
1,012.87 |
1,465.28 |
2,240.58 |
2,274.30 |
| Deffered Credit |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Current Liabilities |
213.39 |
271.72 |
378.96 |
409.64 |
506.06 |
| Provisions |
20.25 |
10.99 |
13.68 |
23.63 |
31.71 |
| Total CL & Provisions |
233.64 |
282.71 |
392.64 |
433.27 |
537.77 |
| Net Current Assets |
676.27 |
730.16 |
1,072.64 |
1,807.31 |
1,736.53 |
| Miscellaneous Expenses |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Total Assets |
1,409.76 |
1,652.71 |
2,110.67 |
2,905.66 |
2,976.25 |
|
| Contingent Liabilities |
98.65 |
114.91 |
130.82 |
79.47 |
180.41 |
| Book Value (Rs) |
148.98 |
155.33 |
169.97 |
174.19 |
227.02 |
|
|
|
|
| Source : Religare Technova |
| Explore Aurobindo Pharm connections |
|
